We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

128 hedge funds and large institutions have $75.2M invested in Ampio Pharmaceuticals Inc. in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

561% more call options, than puts

Call options by funds: $2.71M | Put options by funds: $410K

90% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 20

46% more capital invested

Capital invested by funds: $51.5M → $75.2M (+$23.7M)

22% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 23

16% more funds holding

Funds holding: 110 → 128 (+18)

Holders
128
Holders Change
+18
Holders Change %
+16.36%
% of All Funds
2.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
28
Reduced
23
Closed
20
Calls
$2.71M
Puts
$410K
Net Calls
+$2.3M
Net Calls Change
+$811K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$15.4M
2
State Street
State Street
Massachusetts
+$4.91M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.05M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.76M
5
Northern Trust
Northern Trust
Illinois
+$2.69M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.23M
2
HF
HRT Financial
New York
-$839K
3
ECM
ExodusPoint Capital Management
New York
-$817K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$794K
5
Citadel Advisors
Citadel Advisors
Florida
-$662K
Name Holding Trade Value Shares
Change 		Change in
Stake
BJL
26
Brighton Jones LLC
Washington
$285K -$356K -662 -54%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$272K +$292K +543 New
Simplex Trading
28
Simplex Trading
Illinois
$256K -$68.2K -127 -20%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$235K +$252K +470 New
Morgan Stanley
30
Morgan Stanley
New York
$220K -$39.2K -73 -14%
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$215K +$27.9K +52 +14%
HIS
32
Harvest Investment Services
Illinois
$207K – – –
Deutsche Bank
33
Deutsche Bank
Germany
$206K +$220K +410 New
Osaic Holdings
34
Osaic Holdings
Arizona
$196K -$14K -26 -6%
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$190K +$203K +378 New
CAPTRUST Financial Advisors
36
CAPTRUST Financial Advisors
North Carolina
$188K +$1.07K +2 +0.5%
CC
37
Chicago Capital
Illinois
$185K – – –
LPL Financial
38
LPL Financial
California
$181K +$82.2K +153 +73%
CPIG
39
Chicago Partners Investment Group
Illinois
$177K +$537 +1 +0.2%
TW
40
Transform Wealth
Colorado
$172K -$184K -343 -50%
TCM
41
Traynor Capital Management
Pennsylvania
$155K +$60.7K +113 +55%
GIA
42
GHP Investment Advisors
Colorado
$150K – – –
EWM
43
Empirical Wealth Management
Washington
$139K +$149K +277 New
Invesco
44
Invesco
Georgia
$139K +$149K +278 New
MIM
45
MetLife Investment Management
New Jersey
$132K +$142K +264 New
VOYA Investment Management
46
VOYA Investment Management
Georgia
$128K +$137K +256 New
JP Morgan Chase
47
JP Morgan Chase
New York
$122K +$131K +243 New
CCB
48
Cutter & Co Brokerage
Missouri
$114K – – –
GWM
49
Geneos Wealth Management
Colorado
$112K – – –
DIA
50
Dana Investment Advisors
Wisconsin
$109K – – –
1
2
3 4 5

AMPE Hedge Fund Activity: Q2 2021 in Review

128 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2021, worth a combined $75.2M — up 46% from $51.5M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new AMPE positions and 20 closed out — a net gain of 18 holders — while 28 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $15.4M. The largest seller was Millennium Management, exiting entirely with an estimated $3.23M sold.

  • 128 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2021, up from 110 in Q1 2021.
  • Funds reported $75.2M of Ampio Pharmaceuticals Inc. stock for Q2 2021, up 46% quarter-over-quarter.
  • 38 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2021 and 20 closed out, a net change of +18 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2021 was BlackRock, an estimated $15.4M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2021 was Millennium Management, an estimated $3.23M sold.

Based on aggregated 13F filings for Q2 2021.